Literature DB >> 22461195

Structural analysis of human placental stem and terminal villi from normal and idiopathic growth restricted pregnancies.

Shaima M Almasry1, Magda A Eldomiaty, Amr K Elfayomy, Fawzia A Habib, Maha D Safwat.   

Abstract

Studying in detail different histomorphological and pathological findings in placental stem and terminal villi of appropriate for gestational age (AGA) and idiopathic intrauterine growth restricted (IUGR) fetuses, then analyzing their correlation to the neonatal birth weight and to the some morphological features of the placenta. Fifty full-term human placentae of idiopathic IUGR and 25 of AGA pregnancies were processed for haematoxylin and eosin staining and evaluated by light microscope aided with Image Analyzer. The mean number of stem villous arteries, and the mean number of terminal villous capillaries per field are significantly lower in idiopathic IUGR group (4.63 ± 0.46, 47.09 ± 4.44, respectively) than in AGA group (12.36 ± 0.61, 73.35 ± 5.13, respectively) (p = 0.001). Both AGA and idiopathic IUGR placentae share the presence of many pathological features: (1) narrowing of stem villous arteries appears in 38 (76 %) of IUGR cases and in 9 (36 %) of AGA cases with significant difference between groups (p = 0.001); (2) cellular infiltration (villitis) of the stem villi is significantly higher in IUGR cases [24 (48 %)] than in AGA cases [2 (8 %)] (p = 0.001). The study shows significant correlation between the birth weight and different pathologic features in the stem villi as arterial number (r = 0.494; p = 0.000), arterial narrowing (r = 0.283, p = 0.004), degenerative changes (r = 0.331, p = 0.001) and villitis (r = 0.275, p = 0.005). There is also significant correlation between neonatal birth weight and terminal villous capillary number (r = 0.281, p = 0.001) but no significant correlation is found between the birth weight and terminal villous fibrotic changes (r = -0.098, p = 0.318). Histomorphological and pathological changes in the stem villi could explore the cause of idiopathic IUGR. Stem villous arterial number, arterial narrowing, degeneration and villitis could be underlying mechanisms. Further researches on the hormonal and cytokine level should be undertaken to demonstrate the precipitating factors of these changes and the possible preventing measures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461195     DOI: 10.1007/s10735-012-9405-3

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  31 in total

1.  The role of intraplacental vascular smooth muscle in the dynamic placenta: a conceptual framework for understanding uteroplacental disease.

Authors:  N J Sebire; D Talbert
Journal:  Med Hypotheses       Date:  2002-04       Impact factor: 1.538

2.  Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction.

Authors:  T M Mayhew; C Ohadike; P N Baker; I P Crocker; C Mitchell; S S Ong
Journal:  Placenta       Date:  2003 Feb-Mar       Impact factor: 3.481

3.  Placental pathology of idiopathic intrauterine growth retardation at term.

Authors:  C M Salafia; A M Vintzileos; L Silberman; K F Bantham; C A Vogel
Journal:  Am J Perinatol       Date:  1992-05       Impact factor: 1.862

4.  Pre-eclampsia and fetal growth restriction: how morphometrically different is the placenta?

Authors:  M Egbor; T Ansari; N Morris; C J Green; P D Sibbons
Journal:  Placenta       Date:  2005-08-24       Impact factor: 3.481

5.  Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction.

Authors:  M Egbor; T Ansari; N Morris; C J Green; P D Sibbons
Journal:  BJOG       Date:  2006-03-27       Impact factor: 6.531

Review 6.  Chronic villitis of unknown etiology.

Authors:  Georges Boog
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2007-08-01       Impact factor: 2.435

7.  Elaboration of stem villous vessels in growth restricted pregnancies with abnormal umbilical artery Doppler waveforms.

Authors:  L Macara; J C Kingdom; G Kohnen; A W Bowman; I A Greer; P Kaufmann
Journal:  Br J Obstet Gynaecol       Date:  1995-10

8.  Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies.

Authors:  S Campbell; J M Pearce; G Hackett; T Cohen-Overbeek; C Hernandez
Journal:  Obstet Gynecol       Date:  1986-11       Impact factor: 7.661

9.  Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation.

Authors:  W B Giles; B J Trudinger; P J Baird
Journal:  Br J Obstet Gynaecol       Date:  1985-01

10.  Doppler velocimetry and placental disease.

Authors:  L A Bracero; D Beneck; N Kirshenbaum; M Peiffer; P Stalter; H Schulman
Journal:  Am J Obstet Gynecol       Date:  1989-08       Impact factor: 8.661

View more
  4 in total

1.  Gestational protein restriction induces alterations in placental morphology and mitochondrial function in rats during late pregnancy.

Authors:  Hércules Jonas Rebelato; Marcelo Augusto Marreto Esquisatto; Camila Moraes; Maria Esmeria Corezola Amaral; Rosana Catisti
Journal:  J Mol Histol       Date:  2013-07-25       Impact factor: 2.611

Review 2.  Analysis of homeobox gene action may reveal novel angiogenic pathways in normal placental vasculature and in clinical pregnancy disorders associated with abnormal placental angiogenesis.

Authors:  Padma Murthi; Mohamed Abumaree; Bill Kalionis
Journal:  Front Pharmacol       Date:  2014-06-04       Impact factor: 5.810

3.  Nicotine protects fetus against LPS-induced fetal growth restriction through ameliorating placental inflammation and vascular development in late pregnancy in rats.

Authors:  Junjie Bao; Yong Zou; Yuanyuan Liu; Li Yuan; Robert E Garfield; Huishu Liu
Journal:  Biosci Rep       Date:  2019-07-02       Impact factor: 3.840

Review 4.  Maternal Low Volume Circulation Relates to Normotensive and Preeclamptic Fetal Growth Restriction.

Authors:  Wilfried Gyselaers; Christoph Lees
Journal:  Front Med (Lausanne)       Date:  2022-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.